NCT04703543View on ClinicalTrials.gov

Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

June 9, 2020

Study Completion Date

June 9, 2020

Conditions
Prostate Neoplasms
Interventions
DEVICE

Pilot evaluation study on use PSMA and Cu-PET/CT

This study aims at assessing the detection rate of both PSMA and Cu-PET/CT on tissue relapse, study whether this method is equivalent to mpMR

Trial Locations (1)

00144

Regina Elena National Cancer Institute, Rome

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER

NCT04703543 - Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer | Biotech Hunter | Biotech Hunter